10/21/09, 02:49 AM
|
|
|
|
Join Date: Jun 2009
Location: Waller, Texas
Posts: 80
|
|
Here is some information for people interested in the ongoing research into Casseous Lymphadenitis and the economic impact this disease has on producers.
Our taxes pay for much of this research. It's important to keep up with the new information that is being published daily. There's a lot going on in the goat world.
http://www.ncbi.nlm.nih.gov/pubmed/19405888
http://avmajournals.avma.org/doi/abs/10.2460/javma.234.9.1162
Two sources of an article detailing the results of a comparison of three treatment regimens for goats and sheep with Casseous Lymphadenitis, confirmed to have been caused by C. psuedotuberculosis.
The results are these, 44 caprines (sheep and goats) owned by clients (private owners) were included in the study. All presented with abscesses. The contents of the abscesses were tested and infection with C. pseudotuberculosis was confirmed.
The animals were divided into 3 groups with varying numbers of abscesses (lesions). It is unclear whether any or all of these animals had internal abscesses. From the description, it appears that most, if not all of them had external abscesses, and some may have had internal abscesses, but that information is not included.
Group A had 14 caprines with 15 lesions that were lanced, flushed, and the animals were treated with Penicillin G Procain by subcutaneous injection. 13 out of the 14 animals responded to treatment and the lesions had resolved by 1 month after the trial began, a 92.9% success rate.
Group B included 12 caprines with 15 lesions. These lesions were treated without being lanced by flushing them out (levage) with needle and syringe, then Tulathromycin was injected into each lesion. 14 of the 17 caprines resolved by one month after the trial began, an 83.3% success rate.
Group C included 17 caprines with 18 lesions. This group was treated without lancing the abscesses, by flushing them with a needle and syringe (levage) and with Tulathromycin injections subcutaneously. 14 of the 17 caprines resolved by one month after the study began, a success rate of 82.4%.
The results and conclusions are that CL can be successfully treated in sheep and goats with Tulathromycin in systemic injections. The promise of this new treatment may pave the way for a better relationship between sheep and goat owners if internal CL can be effectively treated in sheep, preventing economic losses.
http://www.sheepandgoatsusa.org/2008Grantees.htm
Scroll down to:
Texas AgriLife Research 2147 TAMU,
The Prevalence of Caeous Lymphadenitis in Selected Goat Populations and the Impact of Treatment with Tulathromycin Versus CUlling Affected Animals
|
